User profiles for Nathalie Morel

Nathalie Morel

Sciences Po, CEE & LIEPP
Verified email at sciencespo.fr
Cited by 3459

[BOOK][B] Towards a social investment welfare state?: ideas, policies and challenges

N Morel, B Palier - 2011 - books.google.com
This book questions whether the recently promoted European'social investment'strategy is
able to regenerate the welfare state, promote social inclusion, create more and better jobs, …

Beyond the welfare state as we knew it?

N Morel, B Palier, J Palme - Towards a social …, 2011 - bristoluniversitypressdigital.com
The twentieth century may be called the century of the welfare state. It saw the emergence,
expansion and maturation of the welfare state as we know it. Some have claimed that these …

[HTML][HTML] Resistance of Omicron subvariants BA. 2.75. 2, BA. 4.6, and BQ. 1.1 to neutralizing antibodies

…, M Saliba, R Sahraoui, F Fémy, N Morel… - Nature …, 2023 - nature.com
Convergent evolution of SARS-CoV-2 Omicron BA.2, BA.4, and BA.5 lineages has led to the
emergence of several new subvariants, including BA.2.75.2, BA.4.6. and BQ.1.1. The …

[HTML][HTML] Screening of 145 anti-PrP monoclonal antibodies for their capacity to inhibit PrPSc replication in infected cells

C Féraudet, N Morel, S Simon, H Volland… - Journal of Biological …, 2005 - ASBMB
Prion diseases are transmissible neurodegenerative disorders affecting humans and animals
for which no therapeutic or prophylactic regimens exist. During the last three years several …

From subsidiarity to 'free choice': Child‐and elder‐care policy reforms in France, Belgium, Germany and the Netherlands

N Morel - Social Policy & Administration, 2007 - Wiley Online Library
This article analyses the patterns of reform in care policies in Bismarckian welfare systems
since the early 1980s. Based on a comparison of France, Germany, Belgium and the …

Rituximab use in the catastrophic antiphospholipid syndrome: descriptive analysis of the CAPS registry patients receiving rituximab

H Berman, I Rodríguez-Pintó, R Cervera, N Morel… - Autoimmunity …, 2013 - Elsevier
The catastrophic variant of the antiphospholipid syndrome (APS) is characterized by
thrombosis in multiple organs developing over a short period of time. First-line treatment for the …

Hydroxychloroquine: a multifaceted treatment in lupus

N Costedoat-Chalumeau, B Dunogue, N Morel… - La Presse Médicale, 2014 - Elsevier
The efficacy of antimalarials, especially hydroxychloroquine (HCQ), in preventing systemic
lupus erythematosus (SLE) flares is well demonstrated. However, many studies show that the …

Systemic inflammatory and autoimmune manifestations associated with myelodysplastic syndromes and chronic myelomonocytic leukaemia: a French multicentre …

…, E Toussirot, G Falgarone, D Launay, N Morel… - …, 2016 - academic.oup.com
Objective. We describe myelodysplastic syndrome (MDS)–associated systemic inflammatory
and autoimmune diseases (SIADs), their treatments and outcomes and the impact of SIADs …

Adherence to treatment in systemic lupus erythematosus patients

…, V Le Guern, G Leroux, D Marra, N Morel… - Best practice & research …, 2013 - Elsevier
Adherence is defined as “the extent to which a person's behaviour coincides with medical or
health advice.” Poor adherence to therapeutic regimens is a common and expensive …

Usefulness of 2‐[18F]‐fluoro‐2‐deoxy‐d‐glucose–Positron Emission Tomography/Computed Tomography for Staging and Evaluation of Treatment Response in …

…, F Bernard, JM Berthelot, N Morel… - Arthritis care & …, 2014 - Wiley Online Library
Objective To evaluate the usefulness of 2‐[ 18 F]‐fluoro‐2‐deoxy‐d‐glucose–positron
emission tomography/computed tomography (FDG‐PET/CT) in IgG4‐related disease (IgG4‐RD) …